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LETTER TO THE EDITOR
A Call for Consistency in the Official Naming of the
Disease Caused by Severe Acute Respiratory Syndrome
Coronavirus 2 in Non-English Languages
Lu Dong, PhD

; Zhe Li, MS

; Isaac Chun Hai Fung, PhD

ABSTRACT
We investigated the adoption of World Health Organization (WHO) naming of COVID-19 into the respective languages among the Group of Twenty (G20) countries, and the variation of COVID-19 naming in
the Chinese language across different health authorities. On May 7, 2020, we identified the websites of
the national health authorities of the G20 countries to identify naming of COVID-19 in their respective
languages, and the websites of the health authorities in mainland China, Hong Kong, Macau, Taiwan
and Singapore and identify their Chinese name for COVID-19. Among the G20 nations, Argentina,
China, Italy, Japan, Mexico, Saudi Arabia and Turkey do not use the literal translation of COVID-19
in their official language(s) to refer to COVID-19, as they retain “novel” in the naming of this disease.
China is the only G20 nation that names COVID-19 a pneumonia. Among Chinese-speaking jurisdictions, Hong Kong and Singapore governments follow the WHO’s recommendation and adopt the literal
translation of COVID-19 in Chinese. In contrast, mainland China, Macau, and Taiwan refer to COVID-19
as a type of pneumonia in Chinese. We urge health authorities worldwide to adopt naming in their native
languages that are consistent with WHO’s naming of COVID-19.
Key Words: COVID-19, infectious disease medicine, naming, SARS-CoV-2

T

he disease caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) was
thought to be a type of pneumonia when it first
emerged in Wuhan. Hence, the National Health
Commission of China (NHC) announced on
February 7, 2020, that the official name of the disease
was novel coronavirus pneumonia (NCP; 新冠肺炎;
Xīnguàn fèiyán).1
On February 11, 2020, the World Health Organization
(WHO) named the disease coronavirus disease 2019
(COVID-19). The name does not include the word
pneumonia. The WHO intentionally excluded the
word novel to give “a standard format to use for any
future coronavirus outbreaks.”2 The WHO provides
official translation of COVID-19 into its 6 working
languages (summarized in https://tinyurl.com/
naming-table-s1); in Chinese, it is the literal translation of COVID-19: “2019 冠状病毒病.”
On February 21, 2020, the NHC announced that they
were changing the English name of the disease to
COVID-19 but were keeping the Chinese name
unchanged.3 Consistent with the name of NCP, the
NHC provides detailed and rather stringent diagnostic

criteria4 that may underdiagnose patients who are
infected with SARS-CoV-2 but do not have explicit
epidemiological links nor show any of the clinical
symptoms (eg, fever and/or respiratory symptoms,
imaging characteristics of NCP). For detailed diagnostic criteria, see https://tinyurl.com/naming-criteriatranslation.
The Chinese official naming as Xīnguàn fèiyán/NCP is
a semantic reflection of an outdated clinical understanding. As we now understand, COVID-19 cases
may be asymptomatic or experience a broad spectrum
of symptoms (eg, cardiovascular symptoms, neurological impairment), with pneumonia presenting only a
portion of the spectrum.5 Given the evolving evidence,
the NHC should reconsider their naming convention
and case definition.
As a comparison, among the G20 nations, Argentina,
China, Italy, Japan, Mexico, Saudi Arabia, and Turkey
do not use the literal translation of COVID-19 in their
official language(s) to refer to this disease on their official websites, as they still retain “novel” in the naming.
China is the only G20 nation that officially refers to
COVID-19 as a type of pneumonia (Appendix).

Disaster Medicine and Public Health Preparedness

e25

Copyright © 2020 Society for Disaster Medicine and Public Health, Inc. This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in
Downloaded from https://www.cambridge.org/core. Georgia Southern University, on 18 May 2021 at 20:47:31, subject to the Cambridge Core terms of use, available at
any medium, provided the original work is properly cited. DOI: 10.1017/dmp.2020.169
https://www.cambridge.org/core/terms. https://doi.org/10.1017/dmp.2020.169

Official Naming of Disease Caused by SARS-CoV-2

Among Chinese-speaking jurisdictions, Hong Kong and
Singaporean Governments adopt the literal translation of
COVID-19 in Chinese. In contrast, mainland China,
Macau, and Taiwan still refer to COVID-19 as a type of pneumonia in Chinese on their official websites (https://tinyurl.
com/naming-table-s2).
The discrepancy between the Chinese and English naming of
the illness, and the corresponding diagnostic criteria of
COVID-19 used in China, should be acknowledged by the
scientific community. It is especially important when we interpret results from Chinese studies concerning COVID-19, as
the Chinese samples may have skewed heavily toward patients
presented with pneumonia. Direct translation of Xīnguàn
fèiyán/NCP into COVID-19, or vice versa, is problematic as
the 2 entities are not equivalent.
Consistent naming will facilitate comparisons of COVID-19related research findings across languages and countries. We
call upon the WHO to ensure all member states to settle on
the same naming of COVID-19 in their respective languages.
Likewise, we urge the NHC to properly adopt the literal translation of COVID-19 into the Chinese language and to update
the diagnostic criteria accordingly.
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